NCT01598038 Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma Status TERMINATED Phase NA
NCT01585974 Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma Status COMPLETED Phase N/A
NCT01582672 Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma Status TERMINATED Phase PHASE3
NCT01566747 Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5 Status COMPLETED Phase PHASE2
NCT01502228 PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma Status TERMINATED Phase NA
NCT01497821 AMG 172 First in Human Study in Patients With Kidney Cancer Status COMPLETED Phase PHASE1
NCT01482949 A Rollover Protocol for Subjects Previously Treated With AGS-003 Status TERMINATED Phase PHASE2
NCT01482520 Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma Status COMPLETED Phase N/A
NCT01473043 Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment Status NO_LONGER_AVAILABLE Phase N/A
NCT01472081 Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016) Status COMPLETED Phase PHASE1
NCT01466504 Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin Status TERMINATED Phase N/A
NCT01442090 Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy Status COMPLETED Phase PHASE2
NCT01441765 PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine Status TERMINATED Phase PHASE2
NCT01441661 Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma Status COMPLETED Phase N/A
NCT01405183 Association Between Hepatitis C Infection and Renal Cell Carcinoma Status COMPLETED Phase N/A
NCT01404104 Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma Status COMPLETED Phase NA
NCT01399918 Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC) Status COMPLETED Phase PHASE2